STAT

5 ways pharma is misleading the public on the cost of prescription drugs

The pharma industry is spending big to improve its image with the public. But experts say the drug industry's narrative is misleading in five key ways.

Drug companies launched an ad and publicity extravaganza this year right after President-elect Donald Trump said they “are getting away with murder” on sky-high pill prices.

More than it has in years, the pharmaceutical industry fears major legislation that would curb prices and shrink profits. TV spots lauding drug companies, quoting poet Dylan Thomas, and showing heroic scientists have been hard to escape.

But the narrative from the industry’s trade group, PhRMA, is only the rosiest, most self-serving version of the tale, say critics, and numerous independent authorities question its assertions.

They say the campaign is misleading in these five ways:

It lowballs drugs’ cost to society

For years, PhRMA said retail prescription drugs account for  of America’s enormous health care bill. Lately, the group has been, counting chemotherapy and other drugs delivered in hospitals and doctor offices.

You're reading a preview, sign up to read more.

More from STAT

STAT6 min readSociety
‘Maisie’s Army’: How A Grassroots Group Is Mobilizing To Help Toddlers Access A Lifesaving Drug
A grassroots group called "Maisie's Army" is mobilizing to help toddlers with a rare disease access a lifesaving drug.
STAT4 min readScience
Scientists Routinely Cure Brain Disorders In Mice But Not Us. A New Study Helps Explain Why
Scientists routinely cure brain disorders in mice but not in humans. A new study helps explain why.
STAT5 min readSociety
Opinion: Community Engagement Is Key To Clinical Trial Recruitment And Diversity
Two birds, one stone: improving diversity in clinical trials will simultaneously improve participation.